Abstract:Objective To evaluate effects of celecoxib (a selective cox-2 inhibitor)combined with fluvastatin (a HMG-CoA reductase inhibitor) on tumor growth and cell apoptosis in hepatocellular carcinoma xenograft in nude mice. Methods Hepatocellular carcinoma BEL-7402 cells were inoculated subcutaneously into the left armpit of nude mice, the mice (n = 32) were then randomly divided into 4 groups: the control group, the celecoxib group,the fluvastatin group and the combination group. At the end of the study,Tumor Tissues were collected for analysis. Cell apoptosis was determined by flow cytometry analysis and TUNEL assay. Akt, p-Akt and survivin protein levels were measured by Western blot. Statistical comparisons were made using factorial analysis of variance (ANOVA) and multiple comparisons between each two groups were calculated using SNK-q test. Results The combination of Celecoxib and fluvastatin resulted in a greater inhibition of tumor growth than either agent alone, the tumor inhibitory rate was 34.0% in the Celecoxib group, 25.0% in the fluvastatin group and 72.2% in the combination group. The percentages of TUNEL--positive cancer cells in the celecoxib and fluvastatin alone treatment groups were 8.5% ± 1.4% and 9.4% ±1.7% respectively as compared to the control group which was 3.5% ± 0.8%. Combination therapy showed a significantly greater increase in tumor cell apoptosis in comparison with the control and single-therapy groups (apoptotic index: 19.4% ± 3.0%; P ＜ 0.01 versus celecoxib or fluvastatin groups). The results of flow cytometry analysis also showed the same tendency. a small number of apoptotic cells were detected in the control tumours (4.1% ± 1.6%), whereas a large number of apoptotic cells were detected in tumours treated with celecoxib (9.1% ± 2.1%) or fluvastatin (10.1% ± 2.3%) alone; and the combination therapy resulted in even more apoptotic cells (23.6% ± 5.8%; P ＜ 0.01 versus celecoxib or fluvastatin groups). Western blot analysis demonstrated that the combination of celecoxib and fluvastatin significantly down-regulated p-Akt (0.23 ± 0.08 versus 1.12 ± 0.07 and surviving (0.50 ± 0.07 versus 1.47 ± 0.19) in BEL-7402 tumours compared with the control (P ＜ 0.01 for all). Conclusion The present study provided evidence that treatment with celecoxib in combination with fluvastatin resulted in the inhibition of HCC tumour growth in an in vivo mouse model. Key words: Carcinoma, hepatocellular; Mice, nude; Apoptosis; Celecoxib; Fluvastatin

The Combined Effects of Celecoxib and Minocycline Hydrochloride on Inhibiting the Osseous Metastasis of Breast Cancer in Nude Mice

A novel therapeutic strategy using ultrasound mediated microbubbles destruction to treat colon cancer in a mouse model.

The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model

Combined effects of celecoxib and NK Cells on growth of SMMC-7721 hepatocellar carcinoma xenografts in nude mice

Effect Of Celecoxib Combined With Chemotherapy Drug On Malignant Biological Behaviors Of Gastric Cancer

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo.

Evaluation of the combined use of metronomic zoledronic acid and Coriolus versicolor in intratibial breast cancer mouse model.

Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma

Synergistic Effect of Docetaxel Combined with Cisplatin on Inhibiting Human Osteosarcoma in Nude Mice

Therapeutic Effects of COX-2 Inhibitor Celecoxib on Nude Mice Bearing Human Pancreatic Cancer Xenograft

The combined use of Camellia sinensis and metronomic zoledronate in 4T1 mouse carcinoma against tumor growth and metastasis.

Celecoxib Enhances the Efficacy of 15-Hydroxyprostaglandin Dehydrogenase Gene Therapy in Treating Murine Breast Cancer

Combined Cetuximab and Celecoxib Treatment Exhibits a Synergistic Anticancer Effect on Human Oral Squamous Cell Carcinoma in Vitro and in Vivo

Increase of Cyclooxygenase-2 Inhibition with Celecoxib Combined with 5-FU Enhances Tumor Cell Apoptosis and Antitumor Efficacy in a Subcutaneous Implantation Tumor Model of Human Colon Cancer

Effection of Celecoxib Combined with 5-Fu on Treatmeat of Human Colorectal Cancer in BALB/C Nude Mice Subcutaneous Xenograft Model

Efficacy of Celebrex in inhibition of breast cancer bone metastasis on a nude mouse model

[Inhibiting Effect of Letrozole Combined with Curcumin on Xenografted Endometrial Carcinoma Growth in Nude Mice].

Antitumor Properties of Taxol in Combination with Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Tumor Growth in Vivo

Synergistic Effect of Celecoxib in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Treatment in Osteosarcoma Cells

Synergistic Inhibitory Activity of Zoledronic Acid and Paclitaxel on Bone Metastasis in Nude Mice

Experimental Study on Selective Cyclooxygenase-2 Inhibitor Combined with Radiotherapy for Human Prostate Carcinoma Xenografts in Nude Mice